Cytokinetics
CYTK
CYTK
178 hedge funds and large institutions have $1.51B invested in Cytokinetics in 2020 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 59 increasing their positions, 57 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
7% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 42
2% less funds holding
Funds holding: 181 → 178 (-3)
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
Holders
178
Holding in Top 10
5
Calls
$14.3M
Puts
$6.65M
Top Buyers
1 | +$51.1M | |
2 | +$43.6M | |
3 | +$43M | |
4 |
BI
BVF Inc
San Francisco,
California
|
+$32.3M |
5 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$20.2M |
Top Sellers
1 | -$55.2M | |
2 | -$48.2M | |
3 | -$36.7M | |
4 |
Citadel Advisors
Miami,
Florida
|
-$25M |
5 |
LGM
Logos Global Management
San Francisco,
California
|
-$16.2M |